Form 4 Tracker
David P Hochman

Director, Chief Executive Officer and Chairperson · 6 filings · Latest: Jun 10, 2026

Orchestra BioMed Holdings, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
OBIO
David P HochmanDirector, Chief Executive Officer and ChairpersonJun 1, 2026
Purchase
$3.835,000$19.1K1,064,029
OBIO
David P HochmanDirector, Chief Executive Officer and ChairpersonMay 15, 2026
Purchase
$3.775,000$18.9K1,059,029
OBIO
David P HochmanDirector, Chief Executive Officer and ChairpersonMar 13, 2026
Purchase
$4.2910,000$42.9K1,086,467